Researchers linked higher weight loss after initiating antiobesity meds to lower risk for revision of hip and knee replacement.

"These results suggest that anti-obesity medication use, with relatively safe and sustainable weight loss, may be an effective strategy for improving implant survivorship of hip and knee replacement ...

Experts say incorporating mental health support into obesity care is critical for effective and sustained outcomes. How can ...

Food companies may be able to satisfy the needs of the growing cohort of GLP-1 medication users while also targeting a ...

Patients who have significant weight loss with anti-obesity medications after joint replacement show reductions in the risk for revision; however, caution on their use is urged as patients recover.

Published results showed patients with obesity who took anti-obesity medications and had postoperative weight loss within 1 ...

The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

While CMS has recently released a memo encouraging Medicare Part D to cover anti-obesity medication, it will only do so if the medication can also help manage diabetes symptoms and reduce the risk ...

Dongxing Xie, MD, PhD, from Central South University in Changsha, China, and colleagues examined the association of the proportion of postoperative weight loss following antiobesity medication use ...